Related Experiment Video
Updated: Jan 22, 2026

05:35
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
Published on: September 15, 2023
2.0K
Chemotherapy Resistance in Advanced Ovarian Cancer Patients.
Ruchika Pokhriyal1, Roopa Hariprasad2, Lalit Kumar3
1Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India.
Biomarkers in Cancer
|July 17, 2019
Summary
This review explores chemotherapy resistance in advanced ovarian cancer, a common gynecologic malignancy. It highlights biomarkers like DNA, RNA, and proteins to predict patient response to treatments such as carboplatin and paclitaxel.
Area of Science:
- Gynecologic Oncology
- Cancer Biology
- Pharmacogenomics
Background:
- Ovarian cancer is a leading cause of cancer death in women, frequently diagnosed at advanced stages.
- Standard treatment involves surgery and chemotherapy (carboplatin/paclitaxel), but resistance limits efficacy.
- Chemotherapy resistance leads to disease relapse and poor prognosis in advanced ovarian cancer patients.
Purpose of the Study:
- To review the challenges of chemotherapy resistance in advanced ovarian cancer.
- To provide an overview of biomarkers for predicting chemotherapy response.
- To enhance understanding of resistance mechanisms at a molecular level.
Main Methods:
- Comprehensive literature review of studies on ovarian cancer chemotherapy resistance.
- Analysis of established and emerging biomarkers (DNA, mRNA, proteins).
- Synthesis of current knowledge on resistance mechanisms and predictive markers.
Main Results:
- Chemotherapy resistance is a significant clinical problem in advanced ovarian cancer.
- Various molecular biomarkers show potential for predicting treatment response.
- Understanding these biomarkers can guide personalized treatment strategies.
Conclusions:
- Biomarkers offer a promising avenue to overcome chemotherapy resistance in ovarian cancer.
- Further research into DNA, RNA, and protein biomarkers is crucial.
- Personalized medicine approaches are key to improving outcomes for ovarian cancer patients.
Related Concept Videos
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
707
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
707
Resistivity
4.4K
When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance
5.7K
When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K
Ovarian Cycle
3.6K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.6K
Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K

